Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A general NIH website-transition notice was added above the ClinicalTrials.gov navigation, and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:15:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:18:21.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, with a minimal header and footer. This indicates that access to the study details is blocked and the content is not available for review.
    Difference
    18%
    Check dated 2026-09-23T01:22:04.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision label updated to Revision: v3.7.0, replacing Revision: v3.6.6; this reflects a page version update without altering the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:20:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a minor page update. No study details or user-facing content were altered.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:27.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was issued, replacing v3.6.4. This reflects a backend/page-system update with no new study details or visible content changes indicated.
    Difference
    0.1%
    Check dated 2026-08-11T17:07:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.